InvestorsHub Logo
Followers 16
Posts 395
Boards Moderated 0
Alias Born 06/07/2009

Re: biopharm post# 141750

Sunday, 09/22/2013 7:08:38 PM

Sunday, September 22, 2013 7:08:38 PM

Post# of 346422
Quote:
.. because "SOME" at the FDA "KNOW" that Bavituximab and the anti-PS platform works well.

Some employees of the FDA may believe or strongly suspect that the anti-PS platform works well and that Peregrine was screwed. The FDA is not its employees. The FDA requires clinical proof or as close to proof as the squishy sciences allow. The FDA cannot permit favoritism or the appearance of favoritism. (Ok, there have been abuses in the past.) But if you think that the FDA will show special consideration to PPHM because of the Fargo screwup I believe you are being delusional.

I just pray that they do not fall to any dirty tricks in Phase III. A BP big brother/protector would be reassuring at this point.

There is simply no correspondence between Cohen and any criminal actions of his hedge fund managers and the FDA and the Fargo imbroglio.

I have a substantial stake riding on the performance of Peregrine and want them to succeed.

I'm annoyed with the management bonuses but not that distressed. I've heard all the complaints about management many times investing in other early stage bio-tecks and tech companies. Some ] went bk, some the management sold out cheap followed by law suites, and some did the hockey stick thing. The latest SRPT and CLDX.

(Sorry for the late response; I biked from my home on Capitol Hill to Mt. Vernon and back then helped a friend set up his wireless network.)

All this in my opinion.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News